Dehydroepiandrosterone and its derivatives: Potentially novel anti-proliferative and chemopreventive agents

被引:21
作者
Matsuzaki, Y.
Honda, A.
机构
[1] Tokyo Med Univ, Kasumigaura Hosp, Div Gastroenterol & Hepatol, Ibaraki 3000395, Japan
[2] Ibaraki Prefectural Inst Publ Hlth, Mito, Ibaraki 3100852, Japan
关键词
dehydroepiandrosterone; metabolites; synthetic analogs; cancer chemoprevention; cancer therapy;
D O I
10.2174/138161206778194015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dehydroepiandrosterone (DHEA) is the most abundant adrenal androgenic steroid in young adult humans. The physiological functions of DHEA in preventing human carcinogenesis are still controversial, but a lot of reports have shown that pharmacological doses of DHEA show chemopreventive and anti-proliferative effects on tumors in rodents. Although a therapeutic dose of DHEA has been reported to promote hepatocarcinogenesis in rats due to peroxisomal proliferation, it remains unclear whether DHEA is a peroxisome proliferator in human liver. The chemopreventive and anti-proliferative effects of DHEA are not explained by a single mechanism, and at least four mechanisms seem to contribute to these effects: 1) depletion of NADPH and ribose-5-phosphate due to the inhibition of glucose-6-phosphate dehydrogenase activity, 2) suppression of cholesterol biosynthetic pathway by inhibition of HMG-CoA reductase, 3) interference with cell proliferation signaling pathways, and 4) suppression of nitric oxide generation through down-regulation of nitric oxide synthase II. In addition to studies of the mechanisms underlying the anti-neoplastic effects, searches for more potent and less androgenic DHEA derivatives are ongoing. A small amount of DHEA is endogenously metabolized to 7-oxygenated DHEA, and this may represent a metabolic pathway to more potent steroid hormones. Androsterone, epiandrosterone and etiocholanolone have been considered to be merely inactive end products of DHEA, but may in fact be physiological effectors in their own right. In addition, DHEA analogs such as 3 beta-methyl-5-androsten-17-one, 16 alpha-fluoro-5-androsten-17-one and 16 alpha-fluoro-5-androstan-17-one have been synthesized and shown to be more effective inhibitors of tumor growth, compared with DHEA itself. However, to design potent and safe DHEA derivatives, identification of the DHFA receptor and clarification of the mechanisms of DHEA action are required.
引用
收藏
页码:3411 / 3421
页数:11
相关论文
共 150 条
[1]   NEUROSTEROID METABOLISM - 7-ALPHA-HYDROXYLATION OF DEHYDROEPIANDROSTERONE AND PREGNENOLONE BY RAT-BRAIN MICROSOMES [J].
AKWA, Y ;
MORFIN, RF ;
ROBEL, P ;
BAULIEU, EE .
BIOCHEMICAL JOURNAL, 1992, 288 :959-964
[2]  
Alberg A, 2001, ANTICANCER RES, V21, P4051
[3]  
Alberg AJ, 2000, CANCER EPIDEM BIOMAR, V9, P517
[4]   THE ROLE OF JUN, FOS AND THE AP-1 COMPLEX IN CELL-PROLIFERATION AND TRANSFORMATION [J].
ANGEL, P ;
KARIN, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (2-3) :129-157
[5]   Adrenal insufficiency [J].
Arlt, W ;
Allolio, B .
LANCET, 2003, 361 (9372) :1881-1893
[6]   Quality of life in Addison's disease - the case for DHEA replacement [J].
Arlt, W .
CLINICAL ENDOCRINOLOGY, 2002, 56 (05) :573-574
[7]  
BERNSTEIN LR, 1994, J BIOL CHEM, V269, P9401
[8]   G6PD deficient cells and the bioreduction of disulfides: Effects of DHEA, GSH depletion and phenylarsine oxide [J].
Biaglow, JE ;
Ayene, IS ;
Koch, CJ ;
Donahue, J ;
Stamato, TD ;
Tuttle, SW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 273 (03) :846-852
[9]   Clinical uses and misuses of dehydroepiandrosterone [J].
Binello, E ;
Gordon, CM .
CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (06) :635-641
[10]   THE EFFECT OF BECLOBRIC ACID AND CLOFIBRIC ACID ON PEROXISOMAL BETA-OXIDATION AND PEROXISOME PROLIFERATION IN PRIMARY CULTURES OF RAT, MONKEY AND HUMAN HEPATOCYTES [J].
BLAAUBOER, BJ ;
VANHOLSTEIJN, CWM ;
BLEUMINK, R ;
MENNES, WC ;
VANPELT, FNAM ;
YAP, SH ;
VANPELT, JF ;
VANIERSEL, AAJ ;
TIMMERMAN, A ;
SCHMID, BP .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (03) :521-528